Mebiopharm to take the IPO plunge on Tokyo AIM market
This article was originally published in Scrip
Executive Summary
After a generally quiet few months on the IPO front in Japan, the Japanese drug delivery venture Mebiopharm has applied to list its shares in mid-July, becoming the first company to trade on the Tokyo AIM market in the process.